Clinical Trial Update: Irbesartan Versus Amlodipine: The OBI Study [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial comparing irbesartan to amlodipine (the OBI study) has been withdrawn. The study enrolled patients with obesity and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Amlodipine (amlodipine)
• Irbesartan (irbesartan)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Obesity, Hypertension | Phase 4 | Status: WITHDRAWN